Olpha Competitors and Similar CompaniesClear all
ANI Pharmaceuticals's competitors and similar companies include Merus and Aerie Pharmaceuticals.
 ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | |
Founding Date | Founding Date 1996 | Founding Date 2003 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Utrecht, NL HQ Cambridge, US | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees 33813% increase | Employees 260 | Employees 3808% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 3.6 b | Valuation ($) 722.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $883.4m (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) | Revenue (est.) $194.1m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $26.8m (FY, 2021) |
Net income | Net income N/A | Net income ($215.3m) (FY, 2024) | Net income ($74.8m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 149.3m | Total funding raised $ 388.6m |
For sources of this data, please see the company profile
View Company Profiles
Merus
HQ
Utrecht, NL
Employees
260
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View companyAerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company